Anti-HSV1 ICP8 Major DNA binding protein antibody [10A3] (ab20193)



  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage bufferPreservative: None
    Constituents: PBS
  • Concentration information loading...
  • PurityIgG fraction
  • ClonalityMonoclonal
  • Clone number10A3
  • MyelomaSp2
  • IsotypeIgG1
  • Light chain typeunknown
  • Research areas


Our Abpromise guarantee covers the use of ab20193 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use at an assay dependent dilution. Predicted molecular weight: 129 kDa.
ICC/IF Use at an assay dependent dilution.


  • RelevanceHerpes simplex type 1 (HSV-1) belongs to a family that includes HSV-2, Epstein-Barr virus (EBV) and Varicella zoster (chicken pox) virus amongst others. HSV-1 and HSV-2 are extremely difficult to distinguish from each other. Members of this family have a characteristic virion structure. The double stranded DNA genome is contained within an icosahedral capsid embedded in a proteinaceous layer (tegument) and surrounded by a lipid envelope, derived from the nuclear membrane of the last host, which is decorated with virus-specific glycoproteins spikes. These viruses are capable of entering a latent phase where the host shows no visible sign of infection and levels of infectious agent become very low. During the latent phase the viral DNA is integrated into the genome of the host cell. ICP8 is the major DNA binding protein of herpes simplex virus type 1.
  • Alternative names
    • DBP antibody
    • Herpes simplex virus type 1 DBP antibody
    • HSV1 DBP antibody
    • ICP8 antibody
    • Infected cell protein 8 antibody
    • Major DNA binding protein antibody
    • UL29 antibody
    see all

Anti-HSV1 ICP8 Major DNA binding protein antibody [10A3] images

  • ab20193 staining HSV1 ICP8 Major DNA binding protein in Human U2OS by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with 0.5% Triton X-100 and blocked with 5% serum for 20 minutes at 22°C. Samples were incubated with primary antibody (1/100) for 1 hour at 22°C. An Alexa Fluor® 488-conjugated Goat anti-mouse IgG polyclonal (1/1000) was used as the secondary antibody.

    See Abreview

References for Anti-HSV1 ICP8 Major DNA binding protein antibody [10A3] (ab20193)

This product has been referenced in:
  • Vogel R  et al. Adeno-associated virus type 2 modulates the host DNA damage response induced by herpes simplex virus 1 during coinfection. J Virol 86:143-55 (2012). Read more (PubMed: 22013059) »
  • Luganini A  et al. Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers. Antimicrob Agents Chemother 55:3231-9 (2011). Read more (PubMed: 21576438) »

See all 6 Publications for this product

Product Wall

Application Immunocytochemistry/ Immunofluorescence
Blocking step Serum as blocking agent for 20 minute(s) · Concentration: 5% · Temperature: 22°C
Sample Human Cell (U2OS)
Specification U2OS
Permeabilization Yes - 0.5% tritonx-100
Fixative Paraformaldehyde

Abcam user community

Verified customer

Submitted Nov 27 2013